New action of Zhejiang Province, another batch of drug price reduction guarantee market

On August 15, Zhejiang drug centralized purchase network released a message "notice on publishing the results of handling online product price complaints of drug centralized purchase in Zhejiang Province (the fifth batch in 2019)", which prompted that some products were complained due to price and other reasons Zhejiang Province has decided to reduce the online transaction price of rosuvastatin calcium tablets and other products from now on through verification, publicity and other procedures At the same time, this also means that another batch of drugs have to reduce the unit price for the sake of the market, facing the same policy requirements as the notice on the withdrawal of some of the original online products published in Shandong last month: "no price reduction, withdraw the Internet" No matter domestic or imported drugs, most of them choose to reduce the price, and the overall implementation effect is obvious On April 19, 2019, the notice on the implementation of the national minimum price linkage results of online trading products in our province and matters related to the 2019 medical insurance payment standard published IPR pharmaceuticals in Puerto Rico, Price of Inc's "rosuvastatin calcium tablets": This article is the reprinted content of yaozhi.com, and the copyright belongs to the original author The purpose of reprinting is to transmit more information, which does not represent the view of this platform If the content of the work, copyright and other issues are involved, please contact our website message, we will delete the content in the first time.